Evidence map›Paper›PMID 38749427›Full record

ArticleAmerican journal of human genetics2024

Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variation.

Zhi Ming Xu, Gnimah Eva Gnouamozi, Sina Rüeger, Patrick R Shea, Maria Buti, Henry Ly Chan, Patrick Marcellin, Dylan Lawless, Olivier Naret, Matthias Zeller and 12 more

Abstract read
In one paragraph

Article in American journal of human genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The potential impacts of human genetics on virus emergence.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Zhi Ming XuSchool of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Gnimah Eva GnouamoziDepartment of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, Heidelberg, Germany.
Sina RüegerSchool of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Patrick R SheaInstitute for Genomic Medicine, Columbia University, New York, NY, USA.
Maria ButiLiver Unit, Hospital Universitario Vall d'Hebron and CIBEREHD del Instituto Carlos III, Barcelona, Spain.
Henry Ly ChanThe Chinese University of Hong Kong, Hong Kong, China.
Patrick MarcellinService d'Hépatologie, Hôpital Beaujon, Clichy, France.
Dylan LawlessSchool of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Olivier NaretSchool of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Matthias ZellerSchool of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Arne SchneuingSchool of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Andreas ScheckSchool of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Thomas JunierSchool of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Darius MoradpourDivision of Gastroenterology and Hepatology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Ondrej PodlahaGilead Sciences Inc, Foster City, CA, USA.
Vithika SuriGilead Sciences Inc, Foster City, CA, USA.
Anuj GaggarGilead Sciences Inc, Foster City, CA, USA.
Mani SubramanianGilead Sciences Inc, Foster City, CA, USA.
Bruno CorreiaSchool of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
David GfellerDepartment of Oncology UNIL-CHUV, Lausanne University Hospital, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Stephan UrbanDepartment of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, Heidelberg, Germany; German Center for Infection Research (DZIF), Partner Site Heidelberg, Heidelberg, Germany.
Jacques FellaySchool of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; Swiss Institute of Bioinformatics, Lausanne, Switzerland; Precision Medicine Unit, Biomedical Data Science Center, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Electronic address: jacques.fellay@epfl.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evolutionary changes in the hepatitis B virus (HBV) genome could reflect its adaptation to host-induced selective pressure. Leveraging paired human exome and ultra-deep HBV genome-sequencing data from 567 affected individuals with chronic hepatitis B, we comprehensively searched for the signatures of this evolutionary process by conducting "genome-to-genome" association tests between all human genetic variants and viral mutations. We identified significant associations between an East Asian-specific missense variant in the gene encoding the HBV entry receptor NTCP (rs2296651, NTCP S267F) and mutations within the receptor-binding region of HBV preS1. Through in silico modeling and in vitro preS1-NTCP binding assays, we observed that the associated HBV mutations are in proximity to the NTCP variant when bound and together partially increase binding affinity to NTCP S267F. Furthermore, we identified significant associations between HLA-A variation and viral mutations in HLA-A-restricted T cell epitopes. We used in silico binding prediction tools to evaluate the impact of the associated HBV mutations on HLA presentation and observed that mutations that result in weaker binding affinities to their cognate HLA alleles were enriched. Overall, our results suggest the emergence of HBV escape mutations that might alter the interaction between HBV PreS1 and its cellular receptor NTCP during viral entry into hepatocytes and confirm the role of HLA class I restriction in inducing HBV epitope variations.

Indexed as

Hepatitis B virusMutationOrganic Anion Transporters, Sodium-DependentSymportersEpitopes, T-LymphocyteGenome, ViralGenomicsHepatitis B, ChronicHepatitis B Surface AntigensHistocompatibility Antigens Class IHost-Pathogen InteractionsHumansProtein PrecursorsEpitopes, T-LymphocyteHepatitis B Surface AntigensHistocompatibility Antigens Class IOrganic Anion Transporters, Sodium-Dependentpresurface protein 1, hepatitis B surface antigenProtein Precursorssodium-bile acid cotransporterSymportersescape variantsevolutionary genomicsHBV entryhepatitis B virushost-pathogen genomicsimmunogeneticsselectionviral restriction

Identifiers

PMID38749427
PMCPMC11179264

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.